Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
mitoBKCa is functionally expressed in murine and human breast cancer cells and potentially contributes to metabolic reprogramming.
Bischof H, Maier S, Koprowski P, Kulawiak B, Burgstaller S, Jasińska J, Serafimov K, Zochowska M, Gross D, Schroth W, Matt L, Juarez Lopez DA, Zhang Y, Bonzheim I, Büttner FA, Fend F, Schwab M, Birkenfeld AL, Malli R, Lämmerhofer M, Bednarczyk P, Szewczyk A, Lukowski R. Bischof H, et al. Among authors: schroth w. Elife. 2024 May 29;12:RP92511. doi: 10.7554/eLife.92511. Elife. 2024. PMID: 38808578 Free PMC article.
Subunits of BK channels promote breast cancer development and modulate responses to endocrine treatment in preclinical models.
Mohr CJ, Schroth W, Mürdter TE, Gross D, Maier S, Stegen B, Dragoi A, Steudel FA, Stehling S, Hoppe R, Madden S, Ruth P, Huber SM, Brauch H, Lukowski R. Mohr CJ, et al. Among authors: schroth w. Br J Pharmacol. 2022 Jun;179(12):2906-2924. doi: 10.1111/bph.15147. Epub 2020 Aug 27. Br J Pharmacol. 2022. PMID: 32468618 Free article.
SK4 channels modulate Ca2+ signalling and cell cycle progression in murine breast cancer.
Steudel FA, Mohr CJ, Stegen B, Nguyen HY, Barnert A, Steinle M, Beer-Hammer S, Koch P, Lo WY, Schroth W, Hoppe R, Brauch H, Ruth P, Huber SM, Lukowski R. Steudel FA, et al. Among authors: schroth w. Mol Oncol. 2017 Sep;11(9):1172-1188. doi: 10.1002/1878-0261.12087. Epub 2017 Jun 26. Mol Oncol. 2017. PMID: 28557306 Free PMC article.
Gene Expression Signatures of BRCAness and Tumor Inflammation Define Subgroups of Early-Stage Hormone Receptor-Positive Breast Cancer Patients.
Schroth W, Büttner FA, Kandabarau S, Hoppe R, Fritz P, Kumbrink J, Kirchner T, Brauer HA, Ren Y, Henderson D, Madden SF, Sauer G, Fehm T, Wallwiener D, Fasching PA, Mürdter T, Schwab M, Brauch H; German Tamoxifen and AI Clinicians Group. Schroth W, et al. Clin Cancer Res. 2020 Dec 15;26(24):6523-6534. doi: 10.1158/1078-0432.CCR-20-1923. Epub 2020 Oct 2. Clin Cancer Res. 2020. PMID: 33008814
Clinical Relevance of CYP2D6 Genetics for Tamoxifen Response in Breast Cancer.
Brauch H, Schroth W, Eichelbaum M, Schwab M, Harbeck N; in cooperation with the AGO TRAFO Comission. Brauch H, et al. Among authors: schroth w. Breast Care (Basel). 2008;3(1):43-50. doi: 10.1159/000114642. Epub 2008 Feb 22. Breast Care (Basel). 2008. PMID: 20824020 Free PMC article.
Tamoxifen use in postmenopausal breast cancer: CYP2D6 matters.
Brauch H, Schroth W, Goetz MP, Mürdter TE, Winter S, Ingle JN, Schwab M, Eichelbaum M. Brauch H, et al. Among authors: schroth w. J Clin Oncol. 2013 Jan 10;31(2):176-80. doi: 10.1200/JCO.2012.44.6625. Epub 2012 Oct 22. J Clin Oncol. 2013. PMID: 23091108 Free PMC article. No abstract available.
69 results